Drug properties & optimzation II 03 (2/3)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/29

encourage image

There's no tags or description

Looks like no tags are added yet.

30 Terms

1
New cards

Lipophilicity importance in drugs

- D's should be

1. Sufficiently hydrophilic to dissolve in biolo fluids

2. Have sufficient lipophilicity to cross memb's when passive diffusion is required

- Appropriate balance deps on the drug, formulation & route of administration.

<p>- D's should be </p><p>1. Sufficiently hydrophilic to dissolve in biolo fluids </p><p>2. Have sufficient lipophilicity to cross memb's when passive diffusion is required </p><p>- Appropriate balance deps on the drug, formulation & route of administration.</p>
2
New cards

LogP (measurements of lipophilicity)

- Logarithm of the octanol/water partition coefficient for neutral form of a compound

- Not pH-dep

- Higher LogP: more lipophilic

- Lower LogP: more hydrophilic

- Formula โ†’

<p>- Logarithm of the octanol/water partition coefficient for neutral form of a compound </p><p>- Not pH-dep</p><p>- Higher LogP: more lipophilic </p><p>- Lower LogP: more hydrophilic</p><p>- Formula โ†’</p>
3
New cards

LogP: rationale for Rule of 5

- LogP describes a neutral compound's preference for octanol vs. water

- High LogP = greater lipophilicity, but excessive may โ†“ aq solubility & limit oral absorption

- Effective oral D's require a balance, not max. lipophilicity

4
New cards

Advantages of LogP

- Well-established measure of lipophilicity

- Useful for comparing molecular structures

- Included in Rule of Five

5
New cards

Limitations of LogP

- Describes the neutral species

- Doesn't directly capture pH-dep ionization

- May not rep. the distribution of ionizable D's under physiolo conditions

6
New cards

LogD (measurements of lipophilicity)

- Distribution btwn octanol & water at a specified pH (7.4)

- Accounts for a compound's non+ionized forms

- pH-dep, unlike LogP

- An intermediate LogD preferred, but no universal optimum

<p>- Distribution btwn octanol & water at a specified pH (7.4) </p><p>- Accounts for a compound's non+ionized forms</p><p>- pH-dep, unlike LogP</p><p>- An intermediate LogD preferred, but no universal optimum</p>
7
New cards

LogD suggested range

1 < Log D7.4 < 3 for many orally administered small-molecule D's, but not a universal requirement

8
New cards

Advantages of LogD

- Accounts for ionization at a specified pH

- Relevant for ionizable D's

- Can study lipophilicity under physiolo relevant conditions

9
New cards

Limitations of LogD

- Deps on pH

- Values measured at diff pH conditions can't be directly compared w/o considering ionization

10
New cards

2 common ways to measure LogP and LogD

1. Shake-flask (solution method)

2. HPLC (High-Performance Liquid Chromatography)

11
New cards

Shake-flask (solution method)

1. Mix drug w octanol & water

2. Allow system to reach equilibrium

3. Measure concen's in both phases

4. Calculate partition or distribution coefficient

<p>1. Mix drug w octanol & water</p><p>2. Allow system to reach equilibrium</p><p>3. Measure concen's in both phases </p><p>4. Calculate partition or distribution coefficient</p>
12
New cards

HPLC (High-Performance Liquid Chromatography)

- Inject sample into a specialized HPLC column calibrated w compounds of known Log P

- Retention time โ†‘ w lipophilicity; use this correlation to estimate Log P

<p>- Inject sample into a specialized HPLC column calibrated w compounds of known Log P </p><p>- Retention time โ†‘ w lipophilicity; use this correlation to estimate Log P</p>
13
New cards

Low LogD_7.4

- Relatively high water solubility

- Low lipid bilayer permeability

- Low oral absorption

- Pic on desktop

<p>- Relatively high water solubility </p><p>- Low lipid bilayer permeability </p><p>- Low oral absorption</p><p>- Pic on desktop</p>
14
New cards

High LogD_7.4

- Low water solubility

- Higher lipid bilayer permeability = poor oral absorption

- Pic on desktop

<p>- Low water solubility</p><p>- Higher lipid bilayer permeability = poor oral absorption</p><p>- Pic on desktop</p>
15
New cards

Very high LogD7.4

- Highly lipophilic D, very low water solubility

- Increased memb permeability to a point, then can get trapped in hydrophobic core of lipid bilayer = poor oral absorption

- Pic on desktop

<p>- Highly lipophilic D, very low water solubility </p><p>- Increased memb permeability to a point, then can get trapped in hydrophobic core of lipid bilayer = poor oral absorption</p><p>- Pic on desktop</p>
16
New cards

Drug permeability

- How readily a D crosses a biolo barrier

- Passive permeability is influenced by lipophilicity, ionization, molecular size, H-bonding capacity

- Solu+permeability r distinct, but both influence oral absorption

17
New cards

Caco-2 Assay (permeability methods)

- Uses layer of cultured human intestinal-like epithelial cells btwn Buffer 1 and 2

- Can reflect passive & transporter-mediated transport

- More complex, costly & time-consuming

<p>- Uses layer of cultured human intestinal-like epithelial cells btwn Buffer 1 and 2</p><p>- Can reflect passive & transporter-mediated transport </p><p>- More complex, costly & time-consuming</p>
18
New cards

PAMPA (Parallel Artificial Membrane Permeability Assay) - permeability methods

- Uses an artificial lipid memb btwn Buffer 1 and 2

- Measures mainly passive permeability

- Simple, rapid and suitable for early screening

19
New cards

Assay methods

1. Place D in Buffer 1 (donor compartment)

2. Allow D to cross memb/cell layer

3. Measure D concen. in Buffer 2 (receiver compartment) over time

4. Compare how readily diff D's cross barrier

20
New cards

Biopharmaceutics Classification System (BCS)

- Classifies D substances based on aq solubility and intestinal permeability

- 4 classes (I-IV)

- Class 1 and 3 immediate-release prods can qualify for BCS-based biowaivers

<p>- Classifies D substances based on aq solubility and intestinal permeability</p><p>- 4 classes (I-IV)</p><p>- Class 1 and 3 immediate-release prods can qualify for BCS-based biowaivers</p>
21
New cards

4 classes of BCS

- Class I: favourable for oral absorp

- Class II: dissolution/solubility can limit absorp

- Class III: permeability can limit absorp.

- Class IV: many oral-delivery challenges

<p>- Class I: favourable for oral absorp </p><p>- Class II: dissolution/solubility can limit absorp</p><p>- Class III: permeability can limit absorp.</p><p>- Class IV: many oral-delivery challenges</p>
22
New cards

Metabolic stability

D's resistance to enzymatic transformation

23
New cards

Phase I of drug metabolism

- Oxidation, reduction and hydrolysis

- May introduce or expose functional groups

- Cytochrome P450

<p>- Oxidation, reduction and hydrolysis </p><p>- May introduce or expose functional groups</p><p>- Cytochrome P450</p>
24
New cards

Cytochrome P450 (Phase I metabolism)

- Cytochrome P450 (CYP) enzymes catalyze many oxidation rxn's

- Contain a heme group w an iron (Fe) center

- Use Oโ‚‚ and e- supplied by NADPH

- Found in liver & tissues

- Can introduce polar groups like -OH

<p>- Cytochrome P450 (CYP) enzymes catalyze many oxidation rxn's </p><p>- Contain a heme group w an iron (Fe) center </p><p>- Use Oโ‚‚ and e- supplied by NADPH </p><p>- Found in liver & tissues</p><p>- Can introduce polar groups like -OH</p>
25
New cards

Catalytic cycle of Cytochrome P450

1. Starts with Fe(III) then undergoes many redox rxn's and addition of Oโ‚‚

2. Fe=O (most reactive iron species) is formed which oxidizes the substrate, then is converted into Fe-O-H via RH

3. ROH is removed and Fe re-enters cycle

- Pic on desktop

<p>1. Starts with Fe(III) then undergoes many redox rxn's and addition of Oโ‚‚</p><p>2. Fe=O (most reactive iron species) is formed which oxidizes the substrate, then is converted into Fe-O-H via RH</p><p> 3. ROH is removed and Fe re-enters cycle </p><p>- Pic on desktop</p>
26
New cards

Determining electron richness

- EDG's can โ†‘ e- density in parts of a molecule & EWG's can โ†“ e- density

- Resonance structures help visualize e- distribution

- E- distribution can affect susceptibility to oxidation

<p>- EDG's can โ†‘ e- density in parts of a molecule & EWG's can โ†“ e- density </p><p>- Resonance structures help visualize e- distribution</p><p>- E- distribution can affect susceptibility to oxidation</p>
27
New cards

Phase II of drug metabolism

- Conjugation rxn's that attach chem groups to D's or metabolites

- Conjugation โ†‘ polarity & facilitates elimination

- Common rxn's: sulfation, acetylation

<p>- Conjugation rxn's that attach chem groups to D's or metabolites</p><p>- Conjugation โ†‘ polarity & facilitates elimination</p><p>- Common rxn's: sulfation, acetylation</p>
28
New cards

Common measurements of metabolic and plasma stability

1. Liver microsomal stability

2. Plasma stability

29
New cards

Liver microsomal stability (measurement of m&p stability)

- Uses subcellular memb preparations from liver tissue

- Assesses metabolism by enzymes present in microsomes, including CYP enzymes

- Can measure D disappearance half-life (Tโ‚/โ‚‚)

<p>- Uses subcellular memb preparations from liver tissue</p><p>- Assesses metabolism by enzymes present in microsomes, including CYP enzymes </p><p>- Can measure D disappearance half-life (Tโ‚/โ‚‚)</p>
30
New cards

Plasma stability (measurement of m&p stability)

- Measures how long a compound remains chemically or enzymatically intact in plasma

- Expressed as (Tโ‚/โ‚‚)

<p>- Measures how long a compound remains chemically or enzymatically intact in plasma </p><p>- Expressed as (Tโ‚/โ‚‚)</p>